Medical occluder device

Information

  • Patent Grant
  • 11484321
  • Patent Number
    11,484,321
  • Date Filed
    Sunday, September 23, 2018
    5 years ago
  • Date Issued
    Tuesday, November 1, 2022
    a year ago
Abstract
An occluder device is provided for occluding a cardiovascular defect or a gap between a medical device and adjacent body tissue, the device including a compliant balloon defining a fluid-tight balloon chamber and a balloon channel forming a longitudinal passage from a proximal to a distal side of the balloon, the balloon including a fluid port for filling a fluid into the balloon chamber. A tip and a base are coupled to the distal and the proximal sides of the balloon, respectively. At least one connecting strut is attached to the tip and to the base. An elongate actuator is disposed longitudinally slidable in the balloon channel and connected to the tip, and longitudinally slidable with respect to the base so as to set a distance between the tip and the base. A lock is configured to maintain the distance between the tip and the base. Other embodiments are also described.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is the U.S. national stage of PCT/EP2018/075716, filed Sep. 23, 2018, which claims priority from European Appl. No. 17192792.4, filed Sep. 23, 2017.


FIELD OF THE INVENTION

The present invention generally relates to an occluder device for occluding a cardiovascular defect or a gap between a medical device and adjacent body tissue. In particular, it relates to a paravalvular leak occluder device. The devices of the present invention are intended to be implantable by means of a percutaneous or minimally invasive intervention.


BACKGROUND OF THE INVENTION

There are several types of unnecessary or even pathologic passageways within the body. If located in blood vessels or in the heart, such passageways can cause a highly undesirable reduction of blood flow or the bypass of blood flow around an organ.


WO 95/32018 discloses a method and a device for blocking a body passageway by inserting an expandable frame into the passageway and expanding the frame with an expandable balloon to partially embed the frame in the walls of the passageway. The frame can be provided with a separate sealing membrane, or the balloon can function as the sealing membrane. The balloon can be removed along with the inflation tube after the expansion step if it is not serving as the sealing membrane, or the balloon can be detached from the inflation tube and left in place, either as a sealing membrane or simply to lock the frame in place. The frame can be maintained in its expanded state by being plastically deformed during the expansion step. The expandable frame has substantially cylindrical shape and is described as being suitable e.g. for closing a patent ductus arteriosus, in which an unwanted passageway or duct connects the aorta to the main pulmonary artery, close to the heart.


U.S. Pat. No. 4,836,204 describes a device for effecting closure of a perforation in the septum of the heart. The device comprises a double-balloon septal defect occlusion catheter which is to be inserted such that the two initially deflated balloons are positioned on opposing sides of the septum. Upon inflating, the balloons snugly engage the respective septum wall sections and thereby prevent leakage through the perforation.


Paravalvular leak is a common complication that occurs in up to 30% of patients under-going implantation of either surgical or transcatheter prostheses. The option to treat these defects percutaneously may offers safer solution for high-risk patients, without exposing them to risk related to open heart reoperation. However, the currently used devices are suboptimal since they have not been specifically developed with this intended use. Today, paravalvular leak closure is generally accomplished with devices originally designed for occlusion of congenital heart defects. They are usually implanted in low flow environment such as patent foramen ovale or atrial septum defect, and in simple geometries. In contrast, paravalvular leaks develop in high pressure and flow environment, and they are characterized by complex geometry. The defect is often crescent or oval shaped, which may include a tubular section with several deformities, and the structure is marginally compliant at best. In this environment, most of the currently avail-able occlusion devices are limited by the poor adaptability of the device to the defect (lack of conformability) and by a lack of intra-device sealing (due to the high flow environment).


Nevertheless, there are some concepts and implementations of occlusion devices that were specifically designed for paravalvular leak occlusion.


US 2014/0277426 A1 describes various devices for occluding a gap between a medical device and adjacent body tissue. The devices generally comprise a conformable body with a hollow interior and provided with a fluid port intended to supply a pressurizing fluid to inflate the conformable body. Various shapes and constitutions of the conformable body, delivery means and fixing means are described.


U.S. Pat. No. 7,628,805 B2 generally discloses a multitude of concepts for locating and for repairing paravalvular leaks. The concepts include sealing stents and also multicomponent and radiation-cured adhesive compounds.


US 2012/078295 A1 discloses an occluder device for closing a passage in a circulatory system. The device comprises an expandable fixation unit for fixing the occluder on the passage, which is achieved by switching between a compact form and an expanded form.


In spite of the above, there is still a need for an improved occluder device which avoids the shortcomings or presently known devices.


SUMMARY OF THE INVENTION

The above and other objects are achieved by the present invention.


According to one aspect, there is provided an occluder device for occluding a cardiovascular defect or a gap between a medical device and adjacent body tissue, the occluder device comprising:

    • a compliant balloon defining a fluid-tight balloon chamber and provided with a balloon channel forming a longitudinal passage from a proximal side to a distal side of the balloon;
    • a tip element disposed at the distal side of the balloon, a base element disposed at the proximal side of the balloon, and connecting means comprising at least one connecting strut attached to the tip element and to the base element, the tip element and the base element each having a guide opening substantially coaxial to the balloon channel for slidingly receiving therein a guidewire for the device;
    • elongated actuating means disposed longitudinally slidable in the balloon channel, releasably connectable to the tip element, and longitudinally slidable with respect to the base element;
    • locking means for maintaining a predetermined distance between the tip element and the base element;
    • proximal connector means for releasably connecting the occluder device to correspondingly configured distal connector means of a catheter device;
    • the balloon comprising a fluid port for filling and unfilling a fluid into and from the balloon chamber.


According to another aspect, there is provided an occluder system comprising an occluder device as defined above and a catheter device cooperating therewith, the catheter device comprising an implant catheter tube connected to an operating handle, the implant catheter tube comprising a longitudinal passageway for a guidewire, distal connector means for releasably connecting the catheter device to correspondingly configured proximal connector means of the occluder device, and a fluid transfer system releasably connectable to a corresponding fluid port of the occluder device. The distal connector means and the proximal connector means are generally configured as cooperating members disposed, respectively, at the distal end of the catheter device and at the proximal end of the occluder device. Examples for such cooperating members comprise cooperating threads, bajonets or snap connections.


Clinical indications include but are not limited to paravalvular leak (PVL), patent foramen ovale (PFO), atrial septum defect (ASD), ventricular septum defect (VSD), intravalvular leak (IVL), intraleaflet leak, leaflet perforation, type I endovascular leaks after vascular graft implant, and left atrial appendage occlusion.


The device is designed to be delivered into the region to be treated in its compressed, i.e. longitudinally extended form, then the device will be adapted to the landing zone anatomy with two mechanisms: inflation of the balloon and shortening of the longitudinal dimension of the frame formed between the base element and the tip element. Under the influence of internal pressure the balloon will assume a certain volume which, for a given longitudinal frame dimension, implies a certain transversal or radial dimension. Changing the longitudinal frame dimension by selecting a different distance between the tip element and the base element will lead to a corresponding change in radial extension. In other words, shortening the distance between the tip element and the base element will lead to a corresponding increase in radial extension under otherwise constant conditions.


In the context of the present disclosure, the terms “distal” and “proximal” are used accordingly to their standard meaning in the field of percutaneous cardiovascular devices. The term “proximal” refers to those components of the device assembly which, when following a delivery catheter during percutaneous delivery, are closer to the end of the catheter that is configured for manipulation by the user (e.g., catheter handle manipulated by a physician). The term “distal” is used to refer to those components of the device assembly that are more distant from the end of the catheter that is configured for manipulation by the user and/or that are inserted further into the body of a patient. Accordingly, in a device for use in a gap between a medical device and the adjacent body tissue, like a paravalvular mitral leak, the proximal end may face towards the left atrium and the distal end may face towards the left ventricle, when the device is deployed in the defect using a transseptal approach.


The term “compliant” used in relation with balloons or with structural components shall be understood as implying a deformability that substantially follows an applied force. Accordingly, a “compliant balloon” shall be understood as a balloon which progressively expands under the effect of increasing radial pressure as long as a certain burst ores-sure is not exceeded.


The connecting means comprise at least one connecting strut attached to the tip element and to the base element. The term “strut” shall be understood as an elongated structural element which can be formed e.g. as a thin wire, rod, thick-walled tube, all of which do not necessarily have a circular cross section.


According to a further aspect, a method of occluding a cardiovascular defect or a gap between a medical device and adjacent body tissue by means of an occluder system as defined above comprises the following steps:

    • providing the occluder system with the occluder device connected to the catheter device;
    • positioning the occluder device in a compressed, longitudinally extended form thereof in a region to be occluded;
    • inflating the balloon by filling a fluid into the balloon chamber;
    • expanding the balloon in radial or lateral direction by shortening the distance between the tip element and the base element to said predetermined distance and locking said distance;
    • releasing the occluder device from the catheter device.


Advantageous embodiments of the invention are defined in the dependent claims and/or are described hereinbelow.


The compliant balloons of the present invention do not need to be pre-shaped. However, pre-shaped balloons can be used to establish a predetermined, non-uniform local resilience against an applied radial pressure. Preferably (claim 2), the balloon is made of a compliant material selected from polycaprolactone (PCL), polyglycolic acid (PGA), polylactic acid (PLA) and polydioxanone (PDO or PDS). Most preferably, the compliant material is PCL.


Depending on the specific application, various configurations of the connecting means may be contemplated. According to one embodiment, the connecting means comprise a single connecting strut disposed within the balloon channel (claim 3) or outside the balloon (claim 4).


Advantageously (claim 5), the connecting means comprise multiple connecting struts disposed in cage-like manner outside the balloon. Applying internal pressure to the balloon will lead to inflation thereof against a resilient force of the compliant balloon material and also against the structural limitation provided by the plurality of external connecting struts. In particular, such a configuration offers the advantage of an improved stability of the compliant balloon against unwanted local deformation. This will generally result in an improved adaptation of the occluder device to the geometry of the leak to be occluded.


The locking means for maintaining a predetermined distance between the tip element and the base element may also be configured in various manners. For example, they may comprise a rotatable actuating wire with a threaded portion formed to cooperate with a corresponding section formed in the distal disk. According to an advantageous embodiment (claim 6), the locking means are configured as a ratchet mechanism whereby said predetermined distance between the tip element and the base element is selectable from a range of distances. This allows for precise and reliable definition of the radial extension of the occluder device and accordingly to an improved reliability of the device.


The elongated actuating means are disposed longitudinally slidable in the balloon channel, releasably connectable to the tip element and longitudinally slidable with respect to the base element. For this purpose, the acutating means are formed as an elongated, flexible member with a smooth surface. According to an advantageous embodiment (claim 7), the elongated actuating means are configured as actuating wire. The use of actuating wires is well established in the field of cardiovascular interventions. In the present context, the use of a wire together with appropriate proximal counterpieces allows for simple, precise and reproducible selection of the distance between the tip element and the base element.


Means for filling and unfilling balloons and other inflatable devices are also well known in the field of cardiovascular interventions. According to an advantageous embodiment (claim 8), the balloon has a fluid port configured as a self-closing valve when it is not connected to a corresponding fluid transfer system. In particular, this allows filling the balloon through a longitudinal fluid line which can subsequently be disconnected and retracted and which only needs to be reinserted and reconnected if an additional filling or an unfilling of the balloon is needed.


The aforementioned elements as well as those claimed and described in the following and to be used according to the invention, shall generally be understood with their meaning as established in the field of medicine.





BRIEF DESCRIPTION OF THE DRAWINGS

The above mentioned and other features and objects of this invention and the manner of achieving them will become more apparent and this invention itself will be better understood by reference to the following description of various embodiments of this invention taken in conjunction with the accompanying drawings, wherein:



FIG. 1 (a) shows a cross-sectional view of an expanded occlusion device according to an embodiment of the invention comprising one connecting component within the balloon embodiment;

    • (b) and (c) show side elevational views of the device illustrated in FIG. 1a;



FIG. 2 (a) shows a cross-sectional view of an expanded occlusion device according to an embodiment of the invention comprising multiple connecting components outside the balloon embodiment;

    • (b) and (c) show side elevational views of the device illustrated in FIG. 2a;



FIG. 3 (a) shows a cross-sectional view of an expanded occlusion device according to an embodiment of the invention comprising one connecting component outside the balloon embodiment;

    • (b) and (c) show side elevational views of the device illustrated in FIG. 3a;



FIG. 4 (a) shows a cross-sectional view of an expanded occlusion device according to an embodiment of the invention when deployed within a cardiovascular defect comprising a ratchet longitudinal adjustment component within the balloon embodiment;

    • (b) and (c) show side elevational views of the device illustrated in FIG. 4a;



FIG. 5 (a) shows a cross-sectional view of the device illustrated in FIG. 4a after the ratchet component actuation and longitudinal shortening;

    • (b) and (c) show side elevational views of the device illustrated in FIG. 5a;



FIG. 6 shows a side view of the device illustrated in FIG. 2a when connected with the implant delivery system comprising a steerable catheter and a multiple knobs delivery handle;



FIG. 7 shows a side view of the device illustrated in FIG. 2a when expanded within a congenital defect;



FIG. 8 shows a side view of the device illustrated in FIG. 2a when expanded within a cardiovascular defect intended as cavity or discontinuity of the body tissue; and



FIG. 9 shows a side view of the device illustrated in FIG. 2a when expanded within a gap between a medical device and the adjacent body tissue.





It will be understood that the figures are not necessarily drawn to scale. In some in-stances, relative dimensions may be substantially distorted for ease of visualization.


DETAILED DESCRIPTION OF THE INVENTION


FIG. 1a shows a cross-sectional view of an expanded occlusion device 20 according to an embodiment of the invention comprising one connecting component within the balloon embodiment. As shown, the device 20 comprises a compliant balloon 5 as well as a central lumen 6 and a frame formed of two plastic or metallic deformable disks, placed at the distal end 10 and proximal end 4 of the implant and connected by one strut 9 passing within the balloon 5 central lumen 6. The frame allows structural support to the balloon. The frame may be formed from a cut structure so that each component of the frame is integrally connected with each other. The strut may have a linear or nonlinear section and may have plastic or metallic deformable characteristics. The occluder forms a closed three-dimensional device. The embodiment comprises a connection element 1 of the device 20 to attach and release it from the implant catheter 14. An inflation port 3 entering into the balloon along the central axis or in the close vicinity of it is connected to the implant catheter 14 and allows inflation and deflation of the balloon 5 while connected before the device 20 release. Within the central lumen 6 of the balloon may be the guidewire lumen 7 allowing a guidewire to freely move axially through the device 20.


According to an embodiment of the present invention, the compliant balloon 5 can be inflated by means of any fluid component, including but not limited to saline solution, blood, foam, liquid polymer that can change its proprieties becoming rigid. This fluid will act as the long-term shape setting, sealing and occluding component of the chronic device 20. The balloon 5 act as acute shape setting, sealing, and as occluding component of the chronic device 20. The implant catheter 14 and the inflation port 3 may contain specific channels, valves and membranes designed to be compatible with the fluid considered, including filter membranes that can be permeable to blood in the case blood is used as filling fluid of the balloon 5.


Moreover, the frame allows longitudinal adjustment of the balloon 5 to enhance device 20 stability and defect occlusion. A locking wire is passing into a locking mechanism 1, within the central lumen 6 and is connected to the distal disk 20. When an actuating wire is placed within the central lumen 6, passing into a locking mechanism 1 in the proximal end of the device 20 and is connected to the distal disk 10, after longitudinal variation of the device 20 dimension by means of change in the distance of the two disks 10 and 4, and after its release from the distal disk 10, the locking mechanism is activated securing the locking wire within its structure, to maintain fixed the distance between the two disks 10 and 4. The actuating wire may be pulled directly by the user, in which case the axial movement of the actuating wire pulls the distal disk 10 in the proximal disk 4 direction. Alternatively, the actuating wire may be rotated by the user, in which case it engages a screw mechanism placed within the locking mechanism 1, so that rotating the wire it pulls the distal disk 10 in the direction of the proximal disk 4 and causes shortening of device 20.


The disks 4, 10 can have a round shape, an elliptical shape or a flower-like shape, an asymmetrical shape or any other shape as necessary or appropriate for proper cardiovascular defects occlusion and device stabilization.


In some embodiments, the frame may be designed to have a limited confirmability, to create a tapered shape to provide asymmetrical confinement to the balloon 5, for example, tapered at the distal end. The frame may have a generally conical, or frusto-conical shape, cylindrical shape, or any other shape as necessary or appropriate.



FIGS. 1b and 1c show side elevational views of the device 20 illustrated in FIG. 1a.



FIGS. 2a to 5c, illustrate further optional features that may be provided in conjunction with the device 20 as presented in the embodiment of FIGS. 1a to 1c. In order to avoid repetitions, only those features differing from the device described above will be ad-dressed. Like reference numbers denominate the same or corresponding features.


As further shown in FIG. 2a the frame may be formed by two proximal 4 and distal 10 plastic or metallic deformable disks, connected by more than one strut 11, which may have any suitable form, passing outside and tapering the balloon 5 component. Such embodiment may allow a cage-like structural confinement of the balloon 5 within its assembly, to avoid unnecessary interference of the device 20 with the body tissue or with implanted prostheses and to provide anchoring support of the device 20 within the cardiovascular defect. In this embodiment of the invention frame may have 2, 4, 6, 8, 10, 12 or any other suitable number of struts.


In some embodiments of the invention, the struts 11 forming the frame may differ in wall thickness and/or width along their entire length or a section thereof. As such, a strut 11 may have a first section that is wider than a second section. In other embodiments, a middle or a distal end section of a strut 11 may be provided with a larger or smaller wall thickness and/or strut width. Varying the wall thickness and/or the strut 11 width can be determined the frame radial stability.



FIGS. 2b and 2c show side elevational views of the device 20 illustrated in FIG. 2a.


As illustrated in FIG. 3a the frame may be formed the two proximal 4 and distal 10 plastic or metallic deformable disks, connected by one strut 12 passing outside and tapering the balloon 5 component.



FIGS. 3b and 3c show side elevational views of the device 20 illustrated in FIG. 3a.


As further shown in FIG. 4a, longitudinal adjustment of the device 20 may be achieved having the locking wire designed as ratchet mechanism 13 that is placed at the proximal disk 4 level and is connected to the actuating wire. This mechanism allows longitudinal adjustment of the device 20 in one way, inhibiting movement in the other direction, so the distal and proximal plates can only come closer, before device 20 release form the implant catheter 14, as shown in FIG. 5a.



FIGS. 4b and 4c show side elevational views of the device 20 illustrated in FIG. 4a.



FIGS. 5b and 5c show side elevational views of the device 20 illustrated in FIG. 5a, equivalent to the FIG. 4a after the ratchet component actuation and longitudinal shortening.



FIG. 6 depicts a perspective view of the device 20 illustrated in FIG. 2a, and of its main components, when connected with the implant catheter 14 comprising a multiple knobs delivery system handle 18.


The implant catheter 14 allow the introduction of the device 20 through the cardiovascular system to a defect in the cardiovascular apparatus, to deploy chronic implant 20 to seal the defect and maintain the occlusion.


The implant catheter 14 is connected to the device 20 through a connection element 1. It comprises within its steerable catheter the device 20, in its deflated not expanded form, and all the components and passage to allow controllable device 20 exposure, inflation, deflation, longitudinal adjustment retrievability and release at the end of the implantation.


Device 20 exposure is controlled by the implant knob 16 in the delivery system handle 18.


It allows the course of the guidewire, used to guide the device 20 to the targeted defect, and of the actuating wire, used to adjust the length of the device 20, within its structure and within the device 20 central lumen 6.


It includes the mechanisms to inflate and deflate of the implant from the balloon 5 inflation port 19 in the handle 18.


It features steerability capability to achieve good positioning of the occlusion device 20 in the cardiac defect, controlled by the steering knob 15 including steering limiter within the delivery system handle 18. The steering capability will allow either anterograde approach from the venous groin to the inferior vena cava, to the right atrium, to the left atrium, or retrograde from the arterial groin to the left ventricle, and be to have the device 20 implanted by any of the techniques known in the art.


In another configuration, the implant catheter 14 is flexible instead that steerable. The balloon 5 implant is one balloon implant fully compliant, where the percentage a balloon v changes in shape, radially and longitudinal, as the pressure and/or the volume of fluid increases in the balloon 5, above the pressure and/or volume necessary for the balloon to reach the minimum targeted shape.


The balloon 5 may be made from any suitable biocompatible material includ-ing polycaprolactone (PCL), Polyglycolic acid (PGA), polylactic acid (PLA), polydioxanone (PDO, PDS).


The frame, comprising the distal 10 and proximal 4 disks and the plethora of struts 9, 11, 12 within the balloon 5 embodiment, has plastic or metallic deformable characteristics, and may be made from any other suitable biocompatible material including stainless steel, titanium, nitinol, tantalum, gold, platinum iridium, tungsten, alloys of any of the above-mentioned met-als, including platinum-iridium alloys, cobalt-chromium alloys, nickel-titanium alloys and nickel-titanium-platinum alloys. Alternatively, it may be made of polymer, including polyester and polycarbonate copolymers, and any metal or polymer or combination of polymer(s) and metal(s) able to soft plastic deformation. Suitable materials include biodegradable materials that are also biocompatible, intending a material that undergoes breakdown or decomposition into non-significant compounds as part of a normal biological process. Suitable biodegradable materials include polylactic acid, polyglycolic acid (PGA), collagen or other connective proteins or natural materials, polycaprolactone, hyaluronic acid, adhesive proteins, co-polymers of these materials as well as composites and combinations thereof and combinations of other biodegradable polymers.


The frame and the balloon of the device 20 according to the invention may be fabricated in different sizes, as necessary or appropriate for use in different sizes of cardiovascular defects or other suitable areas of the body.


Within the initial configuration of the device 20 and implant catheter 14, to allow the device to be introduced in the patient's body, the device 20 is premounted not expanded within the implant catheter 14, and the entire assembly is sterilized.


LIST OF REFERENCE NUMERALS




  • 1 connection


  • 2 locking mechanism


  • 3 inflation port


  • 4 proximal disk


  • 5 balloon


  • 6 foldable balloon lumen


  • 7 guidewire lumen


  • 8 locking wire


  • 9 single internal strut


  • 10 distal disk


  • 11 multiple external struts


  • 12 single external strut


  • 13 ratchet mechanism


  • 14 implant catheter


  • 15 steering knob


  • 16 implant advancement and release knob


  • 17 disk actuating knob


  • 18 delivery system handle


  • 19 balloon inflation port


  • 20 occlusion device


  • 105
    a distal guide opening


  • 105
    b proximal guide opening


  • 106 guidewire


  • 107 catheter device


Claims
  • 1. An occluder device for occluding a cardiovascular defect or a gap between a medical device and adjacent body tissue, the occluder device releasably connected to a catheter device for delivery, the occluder device comprising: a compliant balloon defining a fluid-tight balloon chamber and a balloon channel forming a longitudinal passage from a proximal side to a distal side of the balloon, the balloon comprising a fluid port for filling a fluid into the balloon chamber;a tip and a base, coupled to the distal and the proximal sides of the balloon, respectively;at least one connecting strut attached to the tip and to the base;an elongate actuator disposed longitudinally slidable in the balloon channel and connected to the tip, and longitudinally slidable with respect to the base so as to set a distance between the tip and the base; anda lock configured to maintain the distance between the tip and the base.
  • 2. The occluder device according to claim 1, wherein the occluder device comprises a proximal connector configured to releasably connect the occluder device to the catheter device.
  • 3. The occluder device according to claim 1, wherein the elongate actuator is releasably connected to the tip.
  • 4. The occluder device according to claim 1, wherein the base comprises a disk.
  • 5. The occluder device according to claim 4, wherein the disk is deformable.
  • 6. The occluder device according to claim 1, wherein the base comprises a plate.
  • 7. The occluder device according to claim 1, further comprising a guidewire lumen within the balloon channel, the guidewire lumen open through tip and base guide openings that pass entirely through the tip and the base, respectively.
  • 8. The occluder device according to claim 1, wherein the at least one connecting strut comprises a single connecting strut disposed within the balloon channel.
  • 9. The occluder device according to claim 1, wherein the at least one connecting strut comprises a single connecting strut disposed outside the balloon.
  • 10. The occluder device according to claim 1, wherein the at least one connecting strut comprises multiple connecting struts disposed in a cage-like manner outside the balloon.
  • 11. The occluder device according to claim 1, wherein the lock comprises a ratchet mechanism which is configured to allow selection of the distance between the tip and the base from a range of distances.
  • 12. The occluder device according to claim 1, wherein the elongate actuator comprises an actuating wire.
  • 13. The occluder device according to claim 1, wherein the occluder device is configured such that, when the balloon chamber is filled with the fluid, shortening the distance between the tip and the base radially expands the balloon.
  • 14. The occluder device according to claim 1, wherein the balloon is shaped such that, when the balloon chamber is filled with the fluid, the distal and the proximal sides of the balloon are tapered, and a central portion of the balloon axially between the distal and the proximal sides is cylindrical.
  • 15. The occluder device according to claim 1, wherein the fluid port comprises a self-closing valve.
  • 16. The occluder device according to claim 1, wherein the fluid port is disposed on an external surface of the balloon for filling the fluid into the balloon chamber.
  • 17. The occluder device according to claim 1, wherein the fluid port is configured to allow both filling and unfilling of the fluid into and from the balloon chamber.
  • 18. An occluder system comprising the occluder device according to claim 1, the occluder system further comprising the catheter device, which comprises an operating handle and an implant catheter tube connected to the operating handle, the implant catheter tube shaped so as to define a longitudinal passageway for a guidewire, and an inflation port of a fluid transfer system releasably connectable in fluid communication with the fluid port of the occluder device.
  • 19. A method of occluding a cardiovascular defect or a gap between a medical device and adjacent body tissue, the method comprising: using a catheter device of an occluder system, delivering an occluder device of the occluder system to a region to be occluded while the occluder device is releasably connected to the catheter device, the occluder device including (a) a compliant balloon defining a fluid-tight balloon chamber and a balloon channel forming a longitudinal passage from a proximal side to a distal side of the balloon, (b) a tip and a base, coupled to the distal and the proximal sides of the balloon, respectively, and (c) at least one connecting strut attached to the tip and to the base;positioning the occluder device in a compressed, longitudinally extended form thereof in the region to be occluded;inflating the balloon by filling a fluid into the balloon chamber via a fluid port of the balloon;radially expanding the balloon by shortening a distance between the tip and the base by sliding, with respect to the base, an elongate actuator disposed longitudinally slidable in the balloon channel and connected to the tip;locking the distance between the tip and the base; andreleasing the occluder device from the catheter device.
  • 20. The method according to claim 19, further comprising releasing the elongate actuator from the tip after radially expanding the balloon by shortening the distance between the tip and the base.
  • 21. The method according to claim 19, wherein the occluder device further includes a guidewire lumen within the balloon channel, the guidewire lumen open through tip and base guide openings that pass entirely through the tip and the base, respectively, andwherein delivering the occluder device comprises guiding the occluder device over a guidewire that passes through the guidewire lumen.
  • 22. The method according to claim 19, wherein the at least one connecting strut includes a single connecting strut disposed within the balloon channel.
  • 23. The method according to claim 19, wherein the at least one connecting strut includes a single connecting strut disposed outside the balloon.
  • 24. The method according to claim 19, wherein the at least one connecting strut includes multiple connecting struts disposed in a cage-like manner outside the balloon.
  • 25. The method according to claim 19, wherein the balloon is shaped such that, when the balloon chamber is filled with the fluid, the distal and the proximal sides of the balloon are curved, and a central portion of the balloon axially between the distal and the proximal sides is cylindrical.
Priority Claims (1)
Number Date Country Kind
17192792 Sep 2017 EP regional
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2018/075716 9/23/2018 WO
Publishing Document Publishing Date Country Kind
WO2019/057950 3/28/2019 WO A
US Referenced Citations (396)
Number Name Date Kind
4686962 Haber Aug 1987 A
4802479 Haber et al. Feb 1989 A
5411475 Atala et al. May 1995 A
5499995 Teirstein Mar 1996 A
5795325 Valley Aug 1998 A
5830228 Knapp et al. Nov 1998 A
6117159 Huebsch et al. Sep 2000 A
6174322 Schneidt Jan 2001 B1
6231561 Frazier et al. May 2001 B1
6267747 Samson et al. Jul 2001 B1
6290674 Roue et al. Sep 2001 B1
6328727 Frazier et al. Dec 2001 B1
6334864 Amplatz et al. Jan 2002 B1
6419669 Frazier et al. Jul 2002 B1
6440097 Kupiecki Aug 2002 B1
6468301 Amplatz et al. Oct 2002 B1
6468303 Amplatz et al. Oct 2002 B1
6488689 Kaplan et al. Dec 2002 B1
6537300 Girton Mar 2003 B2
6544268 Lazarus Apr 2003 B1
6551303 Van Tassel et al. Apr 2003 B1
6638257 Amplatz Oct 2003 B2
6652555 VanTassel et al. Nov 2003 B1
6652556 VanTassel et al. Nov 2003 B1
6656488 Yi et al. Dec 2003 B2
6692491 Phan Feb 2004 B1
6926712 Phan Aug 2005 B2
6932816 Phan Aug 2005 B2
6941169 Pappu Sep 2005 B2
6942661 Swanson Sep 2005 B2
6942681 Johnson Sep 2005 B2
6964669 Knapp et al. Nov 2005 B1
6970742 Mann et al. Nov 2005 B2
6994092 Van Der et al. Feb 2006 B2
7011671 Welch Mar 2006 B2
7044134 Khairkhahan et al. May 2006 B2
7056294 Khairkhahan et al. Jun 2006 B2
7169164 Borillo et al. Jan 2007 B2
7211048 Najafi et al. May 2007 B1
7293562 Malecki et al. Nov 2007 B2
7338514 Wahr et al. Mar 2008 B2
7374560 Ressemann et al. May 2008 B2
7470282 Shelso Dec 2008 B2
7473271 Gunderson Jan 2009 B2
7483743 Mann et al. Jan 2009 B2
7549988 Eberl et al. Jun 2009 B2
7597704 Frazier et al. Oct 2009 B2
7604612 Ressemann et al. Oct 2009 B2
7615010 Najafi et al. Nov 2009 B1
7654978 Wahr et al. Feb 2010 B2
7713282 Frazier et al. May 2010 B2
7722641 Van Der Burg et al. May 2010 B2
7735493 Van Der Burg et al. Jun 2010 B2
7740627 Gammie et al. Jun 2010 B2
7749157 Bertolero Jul 2010 B2
7824341 Krishnan Nov 2010 B2
7828818 Zang et al. Nov 2010 B2
7837619 Sogard et al. Nov 2010 B2
7846168 Liddicoat et al. Dec 2010 B2
7846175 Bonnette et al. Dec 2010 B2
7857811 Vaska et al. Dec 2010 B2
7892228 Landis et al. Feb 2011 B2
7918865 Liddicoat et al. Apr 2011 B2
7972359 Kreidler Jul 2011 B2
7976564 Blaeser et al. Jul 2011 B2
7998095 McAuley Aug 2011 B2
7998138 McAuley Aug 2011 B2
8002771 Cox et al. Aug 2011 B2
8034061 Amplatz et al. Oct 2011 B2
8043258 Ostroot Oct 2011 B2
8048147 Adams Nov 2011 B2
8052715 Quinn et al. Nov 2011 B2
8057530 Kusleika et al. Nov 2011 B2
8080032 Van Der Burg et al. Dec 2011 B2
8097015 Devellian Jan 2012 B2
8100938 Figulla et al. Jan 2012 B2
8108069 Stahler et al. Jan 2012 B2
8114123 Brenzel et al. Feb 2012 B2
8133221 Malecki et al. Mar 2012 B2
8142470 Quinn et al. Mar 2012 B2
8148470 Holtcamp et al. Apr 2012 B1
8162974 Eskuri et al. Apr 2012 B2
8163004 Amplatz et al. Apr 2012 B2
8167894 Miles et al. May 2012 B2
8167905 Michler et al. May 2012 B2
8197527 Borillo et al. Jun 2012 B2
8204605 Hastings et al. Jun 2012 B2
8211096 Pless et al. Jul 2012 B2
8221348 Hackett et al. Jul 2012 B2
8221405 Whisenant et al. Jul 2012 B2
8235885 Whisenant et al. Aug 2012 B2
8235988 Davis et al. Aug 2012 B2
8252051 Chau et al. Aug 2012 B2
8257724 Cromack et al. Sep 2012 B2
8257725 Cromack et al. Sep 2012 B2
8308798 Pintor et al. Nov 2012 B2
8313505 Amplatz et al. Nov 2012 B2
8361138 Adams Jan 2013 B2
8366743 Zeng et al. Feb 2013 B2
8372112 Christianson et al. Feb 2013 B2
8398670 Amplatz et al. Mar 2013 B2
8402974 Davis et al. Mar 2013 B2
8408214 Spenser Apr 2013 B2
8409219 Kelley et al. Apr 2013 B2
8463359 Saadat et al. Jun 2013 B2
8480708 Kassab et al. Jul 2013 B2
8491649 Mach Jul 2013 B2
8511214 Gries Aug 2013 B2
8523897 Van Der Burg et al. Sep 2013 B2
8523940 Richardson et al. Sep 2013 B2
8529597 Linder et al. Sep 2013 B2
8540616 Whisenant et al. Sep 2013 B2
8545491 Abboud et al. Oct 2013 B2
8550982 Eby Oct 2013 B2
8568474 Yeung et al. Oct 2013 B2
8574264 Blaeser et al. Nov 2013 B2
8613765 Bonhoeffer et al. Dec 2013 B2
8617145 Longoria Dec 2013 B2
8621975 Russo et al. Jan 2014 B2
8636764 Miles et al. Jan 2014 B2
8647361 Borillo et al. Feb 2014 B2
8647367 Kassab et al. Feb 2014 B2
8652201 Oberti et al. Feb 2014 B2
8663245 Francischelli et al. Mar 2014 B2
8673001 Cartledge et al. Mar 2014 B2
8690911 Miles et al. Apr 2014 B2
8696742 Pintor et al. Apr 2014 B2
8709007 Vaska Apr 2014 B2
8715270 Weitzner et al. May 2014 B2
8721636 Vaska et al. May 2014 B2
8740934 McGuckin, Jr. Jun 2014 B2
8747297 Miyoshi et al. Jun 2014 B2
8747453 Amplatz et al. Jun 2014 B2
8747462 Hill et al. Jun 2014 B2
8758294 Kim et al. Jun 2014 B2
8758372 Cartledge et al. Jun 2014 B2
8758389 Glimsdale Jun 2014 B2
8764787 Ren Jul 2014 B2
8764793 Lee Jul 2014 B2
8771297 Miller et al. Jul 2014 B2
8777974 Amplatz et al. Jul 2014 B2
8778008 Amplatz et al. Jul 2014 B2
8784469 Kassab Jul 2014 B2
8795310 Fung et al. Aug 2014 B2
8795328 Miles et al. Aug 2014 B2
8801706 Rothstein et al. Aug 2014 B2
8801746 Kreidler et al. Aug 2014 B1
8808371 Cartledge Aug 2014 B2
8814778 Kiser et al. Aug 2014 B2
D713527 Heipl Sep 2014 S
8821529 Kariniemi et al. Sep 2014 B2
8834519 Van Der Burg et al. Sep 2014 B2
8840641 Miles et al. Sep 2014 B2
8840655 Edmiston et al. Sep 2014 B2
8845711 Miles et al. Sep 2014 B2
8864809 Miles et al. Oct 2014 B2
8864823 Cartledge et al. Oct 2014 B2
8876776 Kassab et al. Nov 2014 B2
8880185 Hastings et al. Nov 2014 B2
8882830 Cartledge et al. Nov 2014 B2
8900287 Amplatz et al. Dec 2014 B2
8915958 Braido Dec 2014 B2
8940015 Kariniemi Jan 2015 B2
8951251 Willard Feb 2015 B2
8956304 Schecter Feb 2015 B2
8974451 Smith Mar 2015 B2
8979941 Davis et al. Mar 2015 B2
8986375 Garde et al. Mar 2015 B2
D727500 Heipl Apr 2015 S
D727501 Heipl Apr 2015 S
D728102 Heipl Apr 2015 S
9011551 Oral et al. Apr 2015 B2
9017375 Thommen Apr 2015 B2
9023034 Jenson et al. May 2015 B2
9028485 Edmunds et al. May 2015 B2
9034006 Quinn et al. May 2015 B2
9039724 Amplatz et al. May 2015 B2
9039752 Russo et al. May 2015 B2
9050106 Hill et al. Jun 2015 B2
9055933 Escobar et al. Jun 2015 B2
9055959 Vaska et al. Jun 2015 B2
9060761 Hastings et al. Jun 2015 B2
9066710 Dale et al. Jun 2015 B2
9066826 Heidner et al. Jun 2015 B2
9072602 Glozman et al. Jul 2015 B2
9072604 Melnick et al. Jul 2015 B1
9079000 Hanson et al. Jul 2015 B2
9084589 Moszner Jul 2015 B2
9084609 Smith Jul 2015 B2
9084621 Weitzner et al. Jul 2015 B2
9089350 Willard Jul 2015 B2
9089414 Zimmerman et al. Jul 2015 B2
9107750 Cartledge et al. Aug 2015 B2
9113890 Dasnurkar et al. Aug 2015 B2
9119600 Richardson et al. Sep 2015 B2
9119632 Jenson et al. Sep 2015 B2
9125653 Kovach Sep 2015 B2
9131932 Tegels Sep 2015 B2
9132007 Menk et al. Sep 2015 B2
9138208 Linder et al. Sep 2015 B2
9144431 Friedman et al. Sep 2015 B2
9144663 Ahlberg et al. Sep 2015 B2
9155589 Jenson Oct 2015 B2
9161758 Figulla et al. Oct 2015 B2
9162046 Hill et al. Oct 2015 B2
9173696 Schauer et al. Nov 2015 B2
9186174 Krishnan Nov 2015 B2
9186209 Weber et al. Nov 2015 B2
9186210 Jenson Nov 2015 B2
9186211 Mathur Nov 2015 B2
9192435 Jenson Nov 2015 B2
9192790 Hastings et al. Nov 2015 B2
9198683 Friedman et al. Dec 2015 B2
9216014 Devellian et al. Dec 2015 B2
9220402 Rothe et al. Dec 2015 B2
9220487 Davis et al. Dec 2015 B2
9220558 Willard Dec 2015 B2
9220561 Crow et al. Dec 2015 B2
9226838 Wang et al. Jan 2016 B2
9232992 Heidner et al. Jan 2016 B2
9241792 Benichou et al. Jan 2016 B2
9254141 Morris et al. Feb 2016 B2
9254192 Lutter et al. Feb 2016 B2
9271736 Heipl Mar 2016 B2
9277905 Cully et al. Mar 2016 B2
9277915 Belson et al. Mar 2016 B2
9289266 Weitzner et al. Mar 2016 B2
9290612 Martin et al. Mar 2016 B2
9295472 Ottma Mar 2016 B2
9295484 Solem Mar 2016 B2
9297845 Mathur Mar 2016 B2
9301838 Kapadia Apr 2016 B2
9307999 Li et al. Apr 2016 B2
9320525 Khieu et al. Apr 2016 B2
9326751 Hastings May 2016 B2
9326852 Spenser May 2016 B2
9333073 Quadri et al. May 2016 B2
9339274 Dakin May 2016 B2
9345462 Weitzner et al. May 2016 B2
9351716 Miles et al. May 2016 B2
9358365 Smith et al. Jun 2016 B2
9364284 Groff et al. Jun 2016 B2
9370418 Pintor et al. Jun 2016 B2
9375209 Akpinar Jun 2016 B2
9375218 Wheeler et al. Jun 2016 B2
9398951 Alkhatib et al. Jul 2016 B2
9408608 Clark, III et al. Aug 2016 B2
9408661 Haverkost Aug 2016 B2
9408951 Larsen et al. Aug 2016 B2
9414842 Glimsdale et al. Aug 2016 B2
9420955 Weber Aug 2016 B2
9421071 Smith et al. Aug 2016 B2
9427215 Cartledge et al. Aug 2016 B2
9427235 Krishnan Aug 2016 B2
9427550 Dakin et al. Aug 2016 B2
9433760 Subramaniam et al. Sep 2016 B2
9445798 Amplatz et al. Sep 2016 B2
9445799 Amplatz et al. Sep 2016 B2
9456877 Weitzner et al. Oct 2016 B2
9456897 Krivoruchko et al. Oct 2016 B2
9463024 Kiser et al. Oct 2016 B2
9463062 Smith et al. Oct 2016 B2
9468437 Michler et al. Oct 2016 B2
9474516 Clark et al. Oct 2016 B2
9474598 Gregg et al. Oct 2016 B2
9474599 Keränen Oct 2016 B2
9492156 Tegels Nov 2016 B2
9492276 Lee et al. Nov 2016 B2
9492623 Kapadia et al. Nov 2016 B2
9498206 Fung et al. Nov 2016 B2
9498228 Dale et al. Nov 2016 B2
9510811 Akpinar Dec 2016 B2
9532772 Moszner et al. Jan 2017 B2
9545306 Tabor Jan 2017 B2
9572583 Kauphusman et al. Feb 2017 B2
9579030 Scheuermann et al. Feb 2017 B2
9579194 Elizondo et al. Feb 2017 B2
9585643 Terwey Mar 2017 B2
9585644 Linder et al. Mar 2017 B2
9610082 Morris et al. Apr 2017 B2
9622133 Guvenc Apr 2017 B1
9636222 Oslund May 2017 B2
9642706 Eidenschink May 2017 B2
9649115 Edmiston et al. May 2017 B2
9649156 Jenson et al. May 2017 B2
9650730 Heipl et al. May 2017 B2
9655606 Le May 2017 B2
9662205 Eidenschink May 2017 B2
9668811 Sogard et al. Jun 2017 B2
9668856 Para Jun 2017 B2
9668857 Braido et al. Jun 2017 B2
9668858 Morin et al. Jun 2017 B2
9675451 Garde et al. Jun 2017 B2
9681861 Heisel et al. Jun 2017 B2
9687166 Subramaniam et al. Jun 2017 B2
9687341 Alkhatib et al. Jun 2017 B2
9687585 Bernasconi et al. Jun 2017 B2
9693781 Miles et al. Jul 2017 B2
9693821 Hanson et al. Jul 2017 B2
9694115 Zhang et al. Jul 2017 B2
9700323 Clark Jul 2017 B2
9707036 Anderson et al. Jul 2017 B2
9713730 Mathur et al. Jul 2017 B2
9717501 Kauphusman et al. Aug 2017 B2
9730701 Tischler et al. Aug 2017 B2
9737309 Ad Aug 2017 B1
9750605 Ganesan et al. Sep 2017 B2
9757230 Fahim et al. Sep 2017 B2
9770606 Pikus et al. Sep 2017 B2
9775533 Ong et al. Oct 2017 B2
9789232 Liu et al. Oct 2017 B2
9795387 Miles et al. Oct 2017 B2
9795481 Callas et al. Oct 2017 B2
9795765 Romoscanu Oct 2017 B2
9808253 Li et al. Nov 2017 B2
9808300 Hastings et al. Nov 2017 B2
9808311 Wang et al. Nov 2017 B2
9820851 Braido Nov 2017 B2
9820852 Braido et al. Nov 2017 B2
9827039 Dandier et al. Nov 2017 B2
9833283 Hanson et al. Dec 2017 B2
9839430 Willems et al. Dec 2017 B2
9839431 Meyer et al. Dec 2017 B2
9844453 Stack et al. Dec 2017 B2
9848898 Friedman et al. Dec 2017 B2
9848976 Angel et al. Dec 2017 B2
9848981 Suri et al. Dec 2017 B2
9863031 Zhang et al. Jan 2018 B2
9867697 Alkhatib et al. Jan 2018 B2
9877710 Amplatz et al. Jan 2018 B2
9877726 Liu et al. Jan 2018 B2
9878072 Zhang et al. Jan 2018 B2
9883855 Tegels et al. Feb 2018 B2
9883936 Sutton et al. Feb 2018 B2
9888926 Phan et al. Feb 2018 B2
9889004 Braido Feb 2018 B2
9895194 Anderson et al. Feb 2018 B2
9901443 Morriss et al. Feb 2018 B2
9907609 Cao et al. Mar 2018 B2
9913652 Bridgeman et al. Mar 2018 B2
9913715 Braido et al. Mar 2018 B2
9918707 Zhuang Mar 2018 B2
9919080 Chen et al. Mar 2018 B1
9925001 Willard et al. Mar 2018 B2
9931204 Rothstein et al. Apr 2018 B2
9936956 Fung et al. Apr 2018 B2
9943315 Kaplan et al. Apr 2018 B2
9943365 Haverkost et al. Apr 2018 B2
9949825 Braido et al. Apr 2018 B2
9955971 Xu et al. May 2018 B2
9956033 Squire et al. May 2018 B2
9962223 Lindquist et al. May 2018 B2
9974649 Racchini et al. May 2018 B2
9980818 Chau et al. May 2018 B2
9993234 Maslanka et al. Jun 2018 B2
10010402 Wang et al. Jul 2018 B2
10013082 Schecter Jul 2018 B2
10016200 Tegels Jul 2018 B2
10022182 Willard et al. Jul 2018 B2
10028746 Prom Jul 2018 B2
10034748 Tseng et al. Jul 2018 B2
10045784 Friedman et al. Aug 2018 B2
10052168 Krishnan Aug 2018 B2
10058348 Morris et al. Aug 2018 B2
10058636 Xie et al. Aug 2018 B2
10058639 Zhang et al. Aug 2018 B2
10064612 Malakan Rad et al. Sep 2018 B2
10064628 Edmiston et al. Sep 2018 B2
10076330 Sander et al. Sep 2018 B2
10076335 Zaver et al. Sep 2018 B2
10085799 Smith Oct 2018 B2
10098640 Bertolero et al. Oct 2018 B2
10105219 Kovach Oct 2018 B2
10117743 Kumar et al. Nov 2018 B2
10130369 Fung et al. Nov 2018 B2
10130467 Braido et al. Nov 2018 B2
10143478 Forbes Dec 2018 B2
10143551 Braido et al. Dec 2018 B2
20030191516 Weldon et al. Oct 2003 A1
20030220667 Van Der Burg et al. Nov 2003 A1
20040254594 Alfaro Dec 2004 A1
20050288706 Widomski Dec 2005 A1
20060200191 Zadno-azizi et al. Sep 2006 A1
20070135831 Burnett Jun 2007 A1
20070225756 Preinitz et al. Sep 2007 A1
20080071310 Hoffman et al. Mar 2008 A1
20080103479 Cheng et al. May 2008 A1
20120078295 Steiner Mar 2012 A1
20120323270 Lee Dec 2012 A1
20130030519 Tran et al. Jan 2013 A1
20140257457 Glazier et al. Sep 2014 A1
20160045165 Braido et al. Feb 2016 A1
20180008248 Rafiee Jan 2018 A1
20180161039 Harks Jun 2018 A1
20200107836 O'halloran et al. Apr 2020 A1
20210204961 Maisano Jul 2021 A1
Foreign Referenced Citations (48)
Number Date Country
1651117 Jan 2007 EP
1113751 Mar 2007 EP
1154723 Dec 2007 EP
1891902 Feb 2008 EP
1788957 Mar 2008 EP
1881804 Sep 2009 EP
1313406 Jun 2010 EP
1123130 Jul 2010 EP
1948030 Jul 2010 EP
1441649 Aug 2011 EP
1993621 Aug 2011 EP
1842490 Sep 2011 EP
2074953 Jun 2012 EP
2019633 Aug 2012 EP
2248471 Oct 2012 EP
1575421 Oct 2013 EP
2327429 Sep 2014 EP
1761296 Nov 2014 EP
1765225 Sep 2015 EP
2630919 Sep 2015 EP
2822656 Oct 2016 EP
2872051 Mar 2017 EP
2970572 Apr 2017 EP
2779910 May 2017 EP
2967852 Jun 2017 EP
3037043 Sep 2017 EP
2617386 Oct 2017 EP
2819585 Nov 2017 EP
3043746 Nov 2017 EP
3183012 Dec 2017 EP
1768604 Jan 2018 EP
2967869 Jan 2018 EP
3125780 Jan 2018 EP
3044221 Feb 2018 EP
2575678 May 2018 EP
2833836 May 2018 EP
2908744 Aug 2018 EP
2918251 Aug 2018 EP
3193791 Aug 2018 EP
2753246 Nov 2018 EP
3010446 Dec 2018 EP
3459469 Mar 2019 EP
95032018 Nov 1995 WO
1999018886 Apr 1999 WO
2000012169 Mar 2000 WO
2013068466 May 2013 WO
2017079234 May 2017 WO
2017161283 Sep 2017 WO
Non-Patent Literature Citations (6)
Entry
An Intemational Search Report and a Written Opinion both dated Dec. 4, 2018, which issued during the prosecution of Applicant's PCT/EP2018/075716.
An International Search Report and a Written Opinion both dated Jun. 18, 2019, which issued during the prosecution of Applicant's PCT/US2019/024065.
An International Search Report and a Written Opinion both dated Jul. 6, 2021, which issued during the prosecution of Applicant's PCT/IB2021/052474.
An Intemational Search Report and a Written Opinion both dated Mar. 29, 2021, whichissued during the prosecution of Applicant's PCT/IL2020/051041.
European Search Report dated Mar. 12, 2018 which issued during the prosecution of Applicant's European App No. 17192792.4.
An Office Action dated Mar. 7, 2022, which issued during the prosecution of Indian Patent Application No. 202017015683.
Related Publications (1)
Number Date Country
20200275935 A1 Sep 2020 US